The safety and efficacy outcomes of a total of 3 CD19-directed CAR T-cell therapies were confirmed with other real-world data ...

With tremendous social and economic costs, dementia is now the seventh leading cause of death globally, affecting 57 million ...

Nuvectis Pharma's oncology pipeline shows promise, but phase 1 trials and high biotech risk warrant caution. Click here to ...